(Date:9/5/2008)...FRANKLIN, Mass., Sept. 5 /PRNewswire/ -- Arthrosur...eveloper of less-invasive joint,resurfacing system...e U.S.,FDA to begin its pivotal investigation for ...DA stated that "there are no outstanding safety,co...iation., Arthrosurface has been evaluating the sa...
(Date:9/5/2008)...The National Institute of Diabetes and Digestive a...nstitutes of Health (NIH), announces awards to eig...ive studies of urologic chronic pelvic pain disord...rostate. The total research investment for the fiv...ion. , "The launch of this novel research effort...
(Date:9/5/2008)...MIDLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Saturd...e featured on the Oxygen Network show Today,s,Fami...is highlighted as a,leading medical device company...ith effective nebulizers and compressors that deli...ur vision is to improve the lives of those affecte...
(Date:9/5/2008)...ATLANTA, Sept. 5 /PRNewswire/ -- EthicAd, a nonpro...h through consumer education, announces,the launch... public better,understand direct-to-consumer (DTC)..., "Be Smart About Prescription Drug Advertising," ...and Research and was,developed by the FDA in partn...
Breaking Medicine News(10 mins):Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2...for health, especially the role of fats, had been ...nn State University had found out that the between... it is not possible to have the healthy meal by ba...ne particular kind of fats. The right combination ...
...rough in the advancement of scientific technology,...ic mutation at a fraction of cost. It combines the...agonal gel electrophoresis. The technology devised...of Southampton in collaboration with Bristol, Univ...
...y transmitted diseases, incidence is rising among...ng them. AIDS is now a chronic disease and not a f...creased use of methamphetamines (that enhances s...her dimension of new social behaviour is the use ...
...is likely to reduce the risk of contacting HIV fro...0%. A recent study involved 3,000 HIV negative men...umcised and other half were not circumcised. The...archers found that for every ten uncircumcised men...
Other Medicine News:(Date:9/3/2008)...hina, Sept. 3 /- Simcere,Ph...cturer and supplier of,branded generic pharmaceuti...biotech product Endu (also known as Endostar) in C...IV clinical study., At the request of the SFDA, S...her validate the safety and therapeutic efficacy o...
(Date:9/3/2008)...tember is National Vascular Disease Awareness Mont...Diffusion Pharmaceuticals,LLC, a clinical-stage dr...or the treatment of unmet medical needs, announced...hase I/II clinical trial of its lead drug,candidat...nated NCT00725881,on the clinicaltrials.gov Websit...
(Date:9/3/2008)...s showed that Multaq(R) (dronedarone) decreased th...rillation or atrial flutter already a...GEWATER, N.J., Sept. 3 /- T... the ATHENA study were presented today at,the clin...of Cardiology,congress 2008, in Munich, Germany. P...
(Date:9/3/2008)...l Trial Reconfirms Strong Evidence Pycnogenol(R) L...Effect on Joints Following Cessation ...t. 3 /- According to the Center for,D...mon type of arthritis,is on the rise. A new study...esearch, reveals Pycnogenol(R), bark extract from ...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Human Genome Sciences Appoints David P Southwell to its Board of Directors 6709 1Human Genome Sciences Appoints David P Southwell to its Board of Directors 6709 2Human Genome Sciences Appoints David P Southwell to its Board of Directors 6709 3Human Genome Sciences Appoints David P Southwell to its Board of Directors 6709 4Brooks 28R 29 Sports Launches BioMoGo Biodegradable Shoe 24331 1Brooks 28R 29 Sports Launches BioMoGo Biodegradable Shoe 24331 2Brooks 28R 29 Sports Launches BioMoGo Biodegradable Shoe 24331 3EatTurkey com Gets a Healthy Upgrade 24326 1EatTurkey com Gets a Healthy Upgrade 24326 2Clinical Trial Concluded For New Wrinkle Treatment 24321 1Clinical Trial Concluded For New Wrinkle Treatment 24321 2Clinical Trial Concluded For New Wrinkle Treatment 24321 3...THESDA, Md., March 26, 2007--Having a build-up of ...k of heart attacks and,death from heart disease in... from the Multi-Ethnic Study of Atherosclerosis (M... Institute of the,National Institutes of Health. P... artery calcium is linked to greater risk of,heart...
...NEAPOLIS--(BUSINESS WIRE)--Mar 26, 2007 - Two-year...I trial confirm the positive,clinical profile of t...ng to nearly 1,300 the number of Endeavor patients...cantly, among those 1,300,Endeavor patients, there...sis using the independent, pre-specified clinical ...
Other Medicine Technology:Calcium Plaque Build-up in the Arteries Leads to Coronary Heart,Disease in Multi-Ethnic Groups 2Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile 2Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile 3...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: